IO Summit News
Sponsors & Exhibit
Event Features & Attendee Demographics
Lead Generation Opportunities
Custom Event Services
Hotel & Travel
AUGUST 27-28, 2018
AUGUST 28-29, 2018
AUGUST 30-31, 2018
Preclinical & Translational IO
Personalized Cancer Vaccines
IO Biomarkers 1: Immune Profiling and Immune Monitoring
IO Biomarkers 2: Predictive Biomarkers and Companion Diagnostics
Neoantigen Targeted Therapies
Oncolytic Virus Immunotherapy
Adoptive T Cell Therapy 1: Discovery
Adoptive T Cell Therapy 2: Development
Training Seminar 1: CAR-T Engineering for Protein Scientists
Training Seminar 2: Immunology for Drug Discovery Scientists
Immuno-Oncology Investing & Partnering Forum
Short Courses provide in-depth, hands on learning experience!
Round table discussions offer facilitated networking to share cutting-edge IO research.
Immuno-Oncology Summit hosted over 550 international delegates.
People gather for the Plenary Keynote Session focused on immunotherapy reimbursement and regulatory approval.
Poster presenter shares his research in the expanded exhibit hall.
Packed Exhibit Hall provides networking and poster viewing.
Gergana Zlateva, Ph.D., Vice President, Payer Insights and Access, Oncology, Pfizer presents her keynote presentation "Market Access and Reimbursement for Immuno-Oncology Drugs in Today’s Healthcare System."